Products Categories
CAS No.: | 132907-72-3 |
---|---|
Name: | Ramosetron hydrochloride |
Article Data: | 2 |
Molecular Structure: | |
Formula: | C17H18ClN3O |
Molecular Weight: | 315.802 |
Synonyms: | Methanone,(1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-,monohydrochloride, (R)-;Methanone,(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]-,monohydrochloride (9CI);(-)-(R)-5-[(1-Methyl-1H-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazolemonohydrochloride;(R)-(-)-Ramosetron hydrochloride;Irribow;Ramosetronhydrochloride;YM 060; |
Melting Point: | 244-246°C |
Boiling Point: | 579.7 °C at 760 mmHg |
Flash Point: | 304.4 °C |
Hazard Symbols: | Xn |
Risk Codes: | 22 |
PSA: | 50.68000 |
LogP: | 3.69120 |
(R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole
ramosetron hydrochloride
ramosetron
A
5-[(1-methyl-1H-indole-6-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole
B
5-[(1-methyl-1H-indole-5-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole
C
ramosetron hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride In ethanol; ethyl acetate at 70℃; for 1 - 12h; Product distribution / selectivity; | A n/a B n/a C n/a |
What can I do for you?
Get Best Price
The CAS registry number of Methanone,(1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]-,hydrochloride (1:1) is 132907-72-3. The IUPAC name is (1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]methanone hydrochloride (1:1). In addition, the formula is C17H18ClN3O and the molecular weight is 315.79732.
Physical properties about Methanone,(1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]-,hydrochloride (1:1) are: (1)ACD/LogP: 1.99; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.04; (4)ACD/LogD (pH 7.4): 1.59; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 7.56; (7)ACD/KOC (pH 5.5): 3.23; (8)ACD/KOC (pH 7.4): 113.67; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 39.82 Å2; (13)Flash Point: 304.4 °C; (14)Enthalpy of Vaporization: 86.73 kJ/mol; (15)Boiling Point: 579.7 °C at 760 mmHg; (16)Vapour Pressure: 1.96E-13 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: Cl.Clc4cccc(N3CCN(CCCN1/N=C2/C=C\C=C/N2C1=O)CC3)c4
(2)InChI: InChI=1/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H
(3)InChIKey: XIXYTCLDXQRHJO-RFVHGSKJBY
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intravenous | > 30mg/kg (30mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE | Oyo Yakuri. Pharmacometrics. Vol. 47, Pg. 117, 1994. |
dog | LD | oral | > 60mg/kg (60mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS GASTROINTESTINAL: NAUSEA OR VOMITING | Arzneimittel-Forschung. Drug Research. Vol. 45, Pg. 760, 1995. |
mouse | LD50 | intravenous | 90mg/kg (90mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 27, Pg. 652, 1996. | |
rat | LD50 | intravenous | 151mg/kg (151mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Oyo Yakuri. Pharmacometrics. Vol. 47, Pg. 105, 1994. |
rat | LD50 | oral | 1264mg/kg (1264mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 1048, 1999. |